Yoshiyuki Ohtomo

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

Medicine, Nephrology, Pediatrics +14

C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y

Yoshiyuki Ohtomo, Anita Aperia, B. SAHLGREN et al. · Diabetologia · 1996 · 155 citations · Full text

Medicine, Pharmacology, Physiology +17

Differential effects of proinsulin C-peptide fragments on Na + , K + -ATPase activity of renal tubule segments

Yoshiyuki Ohtomo, Tomas Bergman, Bo‐Lennart Johansson et al. · Diabetologia · 1998 · 107 citations · Full text

Life Sciences, Biochemistry, Nephrology +13

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

Shuichiro Fujinaga, Daishi Hirano, Naoto Nishizaki et al. · Pediatric Nephrology · 2010 · 87 citations

Medicine, Nephrology, Pharmacotherapy +6

A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome

Shuichiro Fujinaga, Yoshiyuki Ohtomo, Daisuke Umino et al. · Pediatric Nephrology · 2006 · 81 citations

Medicine, Nephrology, Pediatrics +11